Versor Investments LP Invests $501,000 in Enfusion, Inc. (NYSE:ENFN)

Versor Investments LP bought a new position in Enfusion, Inc. (NYSE:ENFN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 52,800 shares of the company's stock, valued at approximately $501,000.

Other institutional investors have also modified their holdings of the company. Harbor Capital Advisors Inc. boosted its stake in Enfusion by 12.4% in the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company's stock valued at $113,000 after acquiring an additional 1,315 shares in the last quarter. 272 Capital LP boosted its position in Enfusion by 1.5% during the second quarter. 272 Capital LP now owns 139,180 shares of the company's stock worth $1,186,000 after acquiring an additional 2,000 shares during the last quarter. California State Teachers Retirement System boosted its holdings in shares of Enfusion by 11.0% in the 1st quarter. California State Teachers Retirement System now owns 36,002 shares of the company's stock valued at $333,000 after purchasing an additional 3,556 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Enfusion by 27.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 19,562 shares of the company's stock valued at $167,000 after acquiring an additional 4,239 shares during the period. Finally, Allspring Global Investments Holdings LLC purchased a new stake in Enfusion during the 1st quarter worth $44,000. Hedge funds and other institutional investors own 81.05% of the company's stock.

Enfusion Price Performance

ENFN traded down $0.09 on Friday, reaching $9.79. 668,880 shares of the company traded hands, compared to its average volume of 381,949. The company has a market cap of $1.26 billion, a price-to-earnings ratio of 247.50, a PEG ratio of 3.62 and a beta of 0.93. Enfusion, Inc. has a 52-week low of $7.52 and a 52-week high of $10.45. The stock's 50 day moving average price is $8.93 and its 200-day moving average price is $8.85.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.